Trials / Completed
CompletedNCT05183399
Treatment of Patients With Traumatic or Iatrogenic Vessel Injuries
Treatment of Patients With Traumatic or Iatrogenic Vessel Injuries in Thoracic, Abdominal, and Pelvic Arteries
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm device efficacy and safety of the GORE® VIABAHN® Endoprosthesis (hereafter "VB device") for the treatment of traumatic or iatrogenic vessel injury in thoracic, abdominal, and pelvic arteries (except the aorta, coronary, brachiocephalic, carotid, vertebral and pulmonary arteries).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GORE® VIABAHN® Endoprosthesis |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-05-19
- Completion
- 2021-02-14
- First posted
- 2022-01-10
- Last updated
- 2023-01-10
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05183399. Inclusion in this directory is not an endorsement.